METHOD FOR TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION WITH PROSTAGLANDIN ANALGOUES WITHOUT MELANOGENIC SIDE-EFFECT

摘要

Prostaglandin-induced increased pigmentation of the iris can be avoided, orsignificantlyreduced, when using a selective EP2 prostanoid receptor agonist in combinationwith analpha-adrenergic agonist. Methods and compositions for the treatment ofglaucoma and ocularhypertension are described.